HomepageDSKYF • OTCMKTS
add
Daiichi Sankyo
Vorige slotkoers
$Â 18,91
Dag-range
$Â 19,00 - $Â 19,74
Jaar-range
$Â 17,86 - $Â 29,15
Beurswaarde
36,69Â mld. USD
Gem. volume
46,08K
Koers/winst
-
Dividendrendement
-
Primaire beurs
TYO
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (JPY) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 558,11Â mld. | 15,11% |
Bedrijfskosten | 350,29Â mld. | 18,72% |
Netto inkomsten | 86,63Â mld. | 39,89% |
Netto winstmarge | 15,52 | 21,53% |
Winst per aandeel | — | — |
EBITDA | 109,18Â mld. | 38,59% |
Effectief belastingtarief | 18,83% | — |
Balans
Totale activa
Totale passiva
| (JPY) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 541,45Â mld. | -20,63% |
Totale activa | 3,82Â bln. | 10,98% |
Totale passiva | 2,11Â bln. | 16,05% |
Totaal aandelenvermogen | 1,71 bln. | — |
Uitstaande aandelen | 1,85 mld. | — |
Koers-boekwaardeverhouding | 0,02 | — |
Rendement op activa | 6,06% | — |
Rendement op kapitaal | 11,58% | — |
Kasstroom
Nettomutatie in liquide middelen
| (JPY) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 86,63Â mld. | 39,89% |
Operationele kasstroom | 80,06Â mld. | 37,37% |
Kasstroom uit beleggingen | -116,10Â mld. | -661,65% |
Kasstroom uit financiering | 23,00Â mld. | 117,28% |
Nettomutatie in liquide middelen | -708,00Â mln. | 97,23% |
Vrije kasstroom | -159,42Â mld. | -1.296,76% |
Over
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
Opgericht
28 sep 2005
Hoofdvestiging
Website
Werknemers
19.765